Hypophosphatasia
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Hypophosphatasia is a rare inherited disorder characterized by defective bone and teeth mineralization, and deficiency of serum and bone alkaline phosphatase activity. The prevalence of severe forms of the disease has been estimated at 1/100 000. The symptoms are highly variable in their clinical expression, which ranges from stillbirth without mineralized bone to early loss of teeth without bone symptoms. Depending on the age at diagnosis, six clinical forms are currently recognized: perinatal (lethal), perinatal benign, infantile, childhood, adult and odontohypophosphatasia. In the lethal perinatal form, the patients show markedly impaired mineralization in utero. In the prenatal benign form these symptoms are spontaneously improved. Clinical symptoms of the infantile form are respiratory complications, premature craniosynostosis, widespread demineralization and rachitic changes in the metaphyses. The childhood form is characterized by skeletal deformities, short stature, and waddling gait, and the adult form by stress fractures, thigh pain, chondrocalcinosis and marked osteoarthropathy. Odontohypophosphatasia is characterized by premature exfoliation of fully rooted primary teeth and/or severe dental caries, often not associated with abnormalities of the skeletal system. The disease is due to mutations in the liver/bone/kidney alkaline phosphatase gene (ALPL; OMIM# 171760) encoding the tissue-nonspecific alkaline phosphatase (TNAP). The diagnosis is based on laboratory assays and DNA sequencing of the ALPL gene. Serum alkaline phosphatase (AP) activity is markedly reduced in hypophosphatasia, while urinary phosphoethanolamine (PEA) is increased. By using sequencing, approximately 95% of mutations are detected in severe (perinatal and infantile) hypophosphatasia. Genetic counseling of the disease is complicated by the variable inheritance pattern (autosomal dominant or autosomal recessive), the existence of the uncommon prenatal benign form, and by incomplete penetrance of the trait. Prenatal assessment of severe hypophosphatasia by mutation analysis of chorionic villus DNA is possible. There is no curative treatment for hypophosphatasia, but symptomatic treatments such as non-steroidal anti-inflammatory drugs or teriparatide have been shown to be of benefit. Enzyme replacement therapy will be certainly the most promising challenge of the next few years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reaction mechanism of alkaline phosphatase based on crystal structures
Kim, E. E., & Wyckoff, H. W. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90724-k · Cited by 944
Recommendations for a nomenclature system for human gene mutations
Antonarakis, S. E., & Nomenclature Working Group (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:1<1::aid-humu1>3.0.co;2-o · Cited by 943
Hessle, L., Johnson, K. A., Anderson, H. C., Narisawa, S., Sali, A., Goding, J. W., Terkeltaub, R., & Millán, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142063399 · Cited by 864
Hypophosphatasia and the Role of Alkaline Phosphatase in Skeletal Mineralization*
WHYTE, M. P. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-4-439 · Cited by 536
Mammalian Alkaline Phosphatases: From Biology to Applications in Medicine and Biotechnology
Millán, J. L. (2006) · doi:10.1002/3527608060 · Cited by 421 · cited 1×
“In fact, the demonstration that PEA is also a natural substrate of TNAP in vivo remains to be confirmed [53].”
Fraser, D. (1957) · The American Journal of Medicine · doi:10.1016/0002-9343(57)90124-9 · Cited by 389
Structure of the human liver/bone/kidney alkaline phosphatase gene.
Weiss, M. J., Ray, K., Henthorn, P. S., Lamb, B., Kadesch, T., & Harris, H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37885-2 · Cited by 385
Crystal Structure of Alkaline Phosphatase from Human Placenta at 1.8 Å Resolution
Le Du, M. H., Stigbrand, T., Taussig, M. J., Ménez, A., & Stura, E. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009250200 · Cited by 273
Henthorn, P. S., Raducha, M., Fedde, K. N., Lafferty, M. A., & Whyte, M. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9924 · Cited by 264
Mornet, E., Stura, E., Lia-Baldini, A.-S., Stigbrand, T., Ménez, A., & Le Du, M.-H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102788200 · Cited by 218
Self-citationCorrelations of genotype and phenotype in hypophosphatasia
Zurutuza, L. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.6.1039 · Cited by 196
Whyte, M. P., Teitelbaum, S. L., Murphy, W. A., Bergfeld, M. A., & Avioli, L. V. (1979) · Medicine · doi:10.1097/00005792-197909000-00001 · Cited by 171
Adult Hypophosphatasia Treated with Teriparatide
Whyte, M. P., Mumm, S., & Deal, C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1902 · Cited by 165
Hypophosphatasia: The mutations in the tissue-nonspecific alkaline phosphatase gene
Mornet, E. (2000) · Human Mutation · Cited by 151
Self-citationWhyte, M. P., Teitelbaum, S. L., Murphy, W. A., Bergfeld, M. A., & Avioli, L. V. (1979) · PubMed · Cited by 146
Greenberg, C. R., Taylor, C. L. D., Haworth, J. C., Seargeant, L. E., Philipps, S., Triggs‐Raine, B. L., & Chodirker, B. N. (1993) · Genomics · doi:10.1006/geno.1993.1305 · Cited by 135
Mornet, É., Taillandier, A., Peyramaure, S., Kaper, F., MULLER, F. M., Brenner, R. E., Bussière, P., Freisinger, P., Godard, J., Merrer, M. F. L., et al. (1998) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200190 · Cited by 126
Greenberg, C. R., Evans, J. A., McKendry-Smith, S., Redekopp, S., Haworth, J. C., Mulivor, R. A., & Chodirker, B. N. (1990) · PubMed · Cited by 113
A molecular approach to dominance in hypophosphatasia
Lia-Baldini, A.-S., MULLER, F. M., Taillandier, A., Gibrat, J.-F., Mouchard, M.-L., Robin, B., Simon‐Bouy, B., Serre, J., Aylsworth, A., Bieth, É., et al. (2001) · Human Genetics · doi:10.1007/s004390100546 · Cited by 107
Self-citationKinetic Characterization of Hypophosphatasia Mutations With Physiological Substrates
Mauro, S. D., Manes, T. D., Hessle, L., Kozlenkov, A., Pizauro, J. M., Hoylaerts, M., & Millán, J. L. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.8.1383 · Cited by 80
Childhood hypophosphatasia and the premature loss of teeth
Beumer, J., Trowbridge, H. O., Silverman, S., & Eisenberg, E. J. (1973) · Oral Surgery Oral Medicine Oral Pathology · doi:10.1016/0030-4220(73)90028-5 · Cited by 79
Muller, H. L., Yamazaki, M., Michigami, T., Kageyama, T., Schönaü, E., Schneider, P. F., & Ozono, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6373 · Cited by 63
Fukushi-Irie, M., Amizuka, N., Hoshi, K., Ozawa, H., Kumagai, H., Ōmura, S., Misumi, Y., Ikehara, Y., & Oda, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8674 · Cited by 61
Taillandier, A., Cozien, E., MULLER, F. M., Merrien, Y., Bonnin, E., Fribourg, C., Simon‐Bouy, B., Serre, J. L., Bieth, É., Brenner, R. E., et al. (2000) · Human Mutation · Cited by 46
Ito, M., Amizuka, N., Ozawa, H., & Oda, K. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610473 · Cited by 41
Ishida, Y. (2003) · The Journal of Biochemistry · doi:10.1093/jb/mvg114 · Cited by 40
Hérasse, M., Spentchian, M., Taillandier, A., Keppler-Noreuil, K., Fliorito, A. N. M., Bergoffen, J., Wallerstein, R., Muti, C., Simon‐Bouy, B., & Mornet, E. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.8.605 · Cited by 40
Self-citationFukushi-Irie, M., Ito, M., Amaya, Y., Amizuka, N., Ozawa, H., Ōmura, S., Ikehara, Y., & ODA, K. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3480633 · Cited by 39
Heath, I. B., Lia-Baldini, A.-S., Maillard, S., Taillandier, A., Utsch, B., Nuñes, M. E., Serre, J., & Mornet, É. (2007) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2007.06.005 · Cited by 36
Absence of adult dental anomalies in familial hypophosphatasia
Lepe, X., well, B. R. R., Banich, S., & Page, R. C. (1997) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1997.tb00547.x · Cited by 28
Nasu, M., Ito, M., Ishida, Y., Numa‐Kinjoh, N., Komaru, K., Nomura, S., & Oda, K. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05550.x · Cited by 21
Cited by
Excited-state intramolecular proton-transfer (ESIPT) based fluorescence sensors and imaging agents
Sedgwick, A. C., Wu, L., Han, H.-H., Bull, S. D., He, X.-P., James, T. D., Sessler, J. L., Tang, B. Z., Tian, H., & Yoon, J. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00185e · Cited by 1,569
Cellular function and molecular structure of ecto-nucleotidases
Zimmermann, H., Zebisch, M., & Sträter, N. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9309-4 · Cited by 977
The Mechanism of Mineralization and the Role of Alkaline Phosphatase in Health and Disease
Orimo, H. (2010) · Journal of Nippon Medical School · doi:10.1272/jnms.77.4 · Cited by 718
Osteoporosis in young adults: pathophysiology, diagnosis, and management
For the IOF Committee of Scientific Advisors Working Group on Osteoporosis Pathophysiology, Ferrari, S., Bianchi, M. L., Eisman, J. A., Foldes, A. J., Adami, S., Wahl, D. A., Stepan, J. J., de Vernejoul, M.-C., & Kaufman, J.-M. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2030-x · Cited by 255
The Global ALPL gene variant classification project: Dedicated to deciphering variants
Farman, M. R., Rehder, C., Malli, T., Rockman-Greenberg, C., Dahir, K., Martos-Moreno, G. Á., Linglart, A., Ozono, K., Seefried, L., del Angel, G., et al. (2024) · Bone · doi:10.1016/j.bone.2023.116947 · Cited by 68
Metadata
- Authors
- Mornet, E.
- Venue
- Orphanet Journal of Rare Diseases
- Published
- 2007-10-04
- Volume
- 2
- Issue
- 1
- Pages
- 40-40
- ISSN
- 1750-1172 (ISSN-L)
- OpenAlex
- W4231409436
- Cited by
- 274
- References
- 31
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.